Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001721020-26-000002

Director sold 2,625 shares at $10.72 ($28,140)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Seth Alpna Director 2026-06-04 Sale 10b5-1 −2,625 $10.72 $28,140 9,767 D
Open-market sales · 2,625 sh · avg $10.72 · $28,140
Loading xslF345X06/form4-06052026_040607.xml…